Voltage-gated sodium (Na V ) channels are essential for initiating and propagating action potentials in the brain. More than 800 mutations in genes encoding neuronal Na V channels including SCN1A and SCN2A have been associated with human epilepsy. Only one epilepsy-associated mutation has been identified in SCN3A encoding the Na V 1.3 neuronal sodium channel. We performed a genetic screen of pediatric patients with focal epilepsy of unknown cause and identified four novel SCN3A missense variants: R357Q, D766N, E1111K and M1323V. We determined the functional consequences of these variants along with the previously reported K354Q mutation using heterologously expressed human Na V 1.3. Functional defects were heterogeneous among the variants. The most severely affected was R357Q, which had a significantly smaller current density and slower activation than the wild-type (WT) channel as well as depolarized voltage dependences of activation and inactivation. Also notable was E1111K, which evoked a significantly greater level of persistent sodium current than WT channels. Interestingly, a common feature shared by all variant channels was increased current activation in response to depolarizing voltage ramps revealing a functional property consistent with conferring neuronal hyper-excitability. Discovery of a common biophysical defect among variants identified in unrelated pediatric epilepsy patients suggests that SCN3A may contribute to neuronal hyperexcitability and epilepsy.
Introduction
Voltage-gated sodium (Na V ) channels are essential for initiating and propagating action potentials in the brain. The channels exist in a native protein complex composed of a pore-forming α subunit and two smaller accessory β subunits (Catterall, 1988; Isom et al., 1994) . More than 800 sodium channel mutations, mostly in SCN1A and a few in SCN2A, have been associated with epilepsy (Lossin, 2009) . SCN3A is clustered with SCN1A and SCN2A on human chromosome 2q24, but only one mutation in SCN3A, encoding Na V 1.3, is known to be associated with epilepsy (Holland et al., 2008) . The involvement of Na V 1.3 in epilepsy is supported by studies showing that SCN3A mRNA is expressed at higher levels in human CA4 hilar cells in the epileptic hippocampus (Whitaker et al., 2001 ) and in rat neurons of CA1-CA3 and in the dentate granule cell layer after the induction of status epilepticus (Aronica et al., 2001; Bartolomei et al., 1997) . Na V 1.3 channels possess several properties that may cause neuronal hyper-responsiveness. For example, Na V 1.3 channels recover from inactivation rapidly and sustain high-frequency firing (Cummins et al., 2001) , activate during slow ramp depolarizations, and produce persistent sodium current (Chen et al., 2000; Cummins and Waxman, 1997; Estacion et al., 2010; Sun et al., 2007) . The Na V 1.3 epilepsyassociated mutation K354Q was previously demonstrated to enhance persistent current and ramp current (Estacion et al., 2010; Holland et al., 2008) . Several studies indicate that Na V persistent current participates in spontaneous neuronal firing in a variety of cell types including hippocampal neurons (Agrawal et al., 2001; Kearney et al., 2001 ) and subicular neurons isolated from patients with temporal lobe epilepsy (Vreugdenhil et al., 2004) . Moreover, several epilepsyassociated Na V 1.1 mutations are known to enhance persistent current (Kahlig et al., 2008; Lossin et al., 2002; Rhodes et al., 2004; Spampanato et al., 2004) .
We performed a genetic screen of pediatric patients with cryptogenic focal epilepsy and identified four novel SCN3A missense variants: R357Q, D766N, E1111K and M1323V. Electrophysiological studies revealed a diversity of functional defects, but interestingly, all mutant channels exhibited abnormal current activation during a slow depolarizing voltage ramp. This common defect among the novel alleles could explain neuronal hyperexcitability.
Materials and methods

Study subjects
Subjects were ascertained from the St. Louis Children's Hospital Pediatric Epilepsy Center and the Cincinnati Children's Hospital Neurobiology of Disease 62 (2014) 313-322 
